Latest: FDA Approves New Biosimilar for Oncology Treatment

Johnny Cheng appointed as interim CEO of HUTCHMED

0 Mins
HUTCHMED has announced that Weiguo Su, CEO of the company, will take a leave of absence from his duties due to health reasons. As a result, the board of directors has appointed Johnny Cheng, an executive director and chief financial officer (CFO) of the company, as acting CEO with immediate effect, in addition to his […]
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago